date,title,source
Nov-13-18,Evoke Pharma Reports Third Quarter 2018 Results,GlobeNewswire
Jan-04-19,"Loss-Making Evoke Pharma, Inc. (NASDAQ:EVOK) Expected To Breakeven",Simply Wall St.
Jan-07-19,Evoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti in the U.S. with Novos Growth Partners,GlobeNewswire
Feb-27-19,Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results,GlobeNewswire
Mar-04-19,Evoke Pharma Receives Preliminary FDA Communication on Gimoti NDA,GlobeNewswire
Mar-06-19,Evoke Pharma Reports Fourth Quarter and Full Year 2018 Financial Results and FDA Communication,GlobeNewswire
Mar-14-19,Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA,GlobeNewswire
